Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti JP, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaüser M, Hale G, Verdonck L, Cairo M, Gupta V, Pavletic S; Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA. Ratanatharathorn V, et al. Among authors: arora m. Br J Haematol. 2009 Jun;145(6):816-24. doi: 10.1111/j.1365-2141.2009.07674.x. Epub 2009 Mar 26. Br J Haematol. 2009. PMID: 19344418 Free PMC article.
Chronic graft-versus-host disease: a prospective cohort study.
Arora M, Burns LJ, Davies SM, Macmillan ML, Defor TE, Miller WJ, Weisdorf DJ. Arora M, et al. Biol Blood Marrow Transplant. 2003 Jan;9(1):38-45. doi: 10.1053/bbmt.2003.50003. Biol Blood Marrow Transplant. 2003. PMID: 12533740 Free article.
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M, Parker P, Forman S, Weisdorf D, Gurney JG, Baker KS. Fraser CJ, et al. Among authors: arora m. Blood. 2006 Oct 15;108(8):2867-73. doi: 10.1182/blood-2006-02-003954. Epub 2006 Jun 20. Blood. 2006. PMID: 16788100 Free PMC article.
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
Giralt SA, Arora M, Goldman JM, Lee SJ, Maziarz RT, McCarthy PL, Sobocinski KA, Horowitz MM; Chronic Leukemia Working Committee, Center for International Blood and Marrow Transplant Research. Giralt SA, et al. Among authors: arora m. Br J Haematol. 2007 Jun;137(5):461-7. doi: 10.1111/j.1365-2141.2007.06582.x. Epub 2007 Apr 24. Br J Haematol. 2007. PMID: 17459051 Free article.
Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).
Arora M, Nagaraj S, Wagner JE, Barker JN, Brunstein CG, Burns LJ, Defor TE, McMillan ML, Miller JS, Weisdorf DJ. Arora M, et al. Biol Blood Marrow Transplant. 2007 Oct;13(10):1145-52. doi: 10.1016/j.bbmt.2007.06.004. Epub 2007 Jul 27. Biol Blood Marrow Transplant. 2007. PMID: 17889350 Free article.
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Majhail NS, Brunstein CG, Tomblyn M, Thomas AJ, Miller JS, Arora M, Kaufman DS, Burns LJ, Slungaard A, McGlave PB, Wagner JE, Weisdorf DJ. Majhail NS, et al. Among authors: arora m. Biol Blood Marrow Transplant. 2008 Mar;14(3):282-9. doi: 10.1016/j.bbmt.2007.12.488. Biol Blood Marrow Transplant. 2008. PMID: 18275894 Free PMC article. Clinical Trial.
1,424 results